Angene Chemical
Draw
|
Currency :
Home Products

AG008TFD

1110813-31-4 | Dacomitinib (PF299804)

Chemical structure of Dacomitinib (PF299804), CAS 1110813-31-4
AG008TFD
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 1110813-31-4
Catalog Number AG008TFD(AGN-PC-0WA2EJ)
Chemical Name Dacomitinib (PF299804)
IUPAC Name (E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide
InChI InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
InChI Key LVXJQMNHJWSHET-AATRIKPKSA-N
MDL Number MFCD19443734
Molecular Formula C24H25ClFN5O2
Molecular Weight 469.9390
SMILES O=C(NC1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OC)/C=C/CN4CCCCC4
UNII 2XJX250C20
Synonyms
dacomitinib, N-(4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-2-butenamide, PF 00299804, PF-00299804, PF00299804, Dacomitinib, 1110813-31-4, PF299804, Dacomitinib (PF299804, PF299), PF-00299804, UNII-2XJX250C20, pf00299804, (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide, 2XJX250C20, PF299, PF 00299804-03, (E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide, PF-00299804-03, C24H25ClFN5O2, J-500784, Dacomitinib [USAN:INN], (2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide, dacomitinibum, Vizimpro, (E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide, Dacomitinib anhydrous, PF-299804, Dacomitinib (USAN/INN), PF 00299804, Dacomitinib, PF299804, Dacomitinib (PF299804), MLS006011275, GTPL7422, CHEMBL2110732, PF-00299804 dacomitinib, CHEBI:91466, DTXSID50149493, EX-A030, QCR-174, CHEBI:132268, BDBM112499, AOB87383, AOB87735, BCP02530, ABP000126, MFCD19443734, PF-299, s2727, ZINC72266312, AKOS025401818, CS-0500, DB11963, RL00451, SB21754, US8623883, No. 2, NCGC00263185-09, AC-25915, BC261945, HY-13272, SC-94589, SMR004703025, PF299804|||PF299, AB0035896, D5450, SW219155-1, Y0338, D09883, Dacomitinib (PF299804, PF-00299804), PF-299804 (Dacomitinib PF-00299804), Q-4059, 1110813-31-4 pound not PF 299804 pound not PF-299804, (2E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide, (E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide, 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-, (2E)-, Dacomitinib [USAN], D06XXH, cc-194, DACOMITINIB(PF299804), ACN-031538, ACN-039804, CID11511120, A8319, A11051, C525726, PF-299804, PF-00299804, 1042385-75-0, Dacomitinib, 98%, a potent irreversible ErbB inbibitor - 10MG 10mg, N-(4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-2-butenamide, (E)-N-[4-[(3-chloro-4-fluoro-phenyl)amino]-7-methoxy-quinazolin-6-yl]-4-(1-piperidyl)but-2-enamide, 143851-98-3, 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-, (2E)-,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited